Synairgen plans to cancel its shares on London's AIM market and re-register as a private limited company due to failing to meet a fund-raising condition. This move is expected to reduce costs and enhance the company's ability to raise capital.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay